Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/13543784.2020.1821645

http://scihub22266oqcxt.onion/10.1080/13543784.2020.1821645
suck pdf from google scholar
32896184!7544916!32896184
unlimited free pdf from europmc32896184    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32896184      Expert+Opin+Investig+Drugs 2020 ; 29 (11): 1195-1198
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Remdesivir, a remedy or a ripple in severe COVID-19? #MMPMID32896184
  • Doggrell SA
  • Expert Opin Investig Drugs 2020[Nov]; 29 (11): 1195-1198 PMID32896184show ga
  • INTRODUCTION: In clinical trial for the Ebola virus, the broad-spectrum anti-viral agent remdesivir was shown to have a good safety profile. Remdesivir is now being tested in severe COVID-19. AREAS COVERED: The Gilead Sciences SIMPLE trial suggests that the short-term use of remdesivir probably does not increase mortality dramatically or have serious short-term toxicity when used to treat severe COVID-19. The Adaptive COVID-19 treatment trials (ACTT1) trial showed that remdesivir may shorten recovery and decrease mortality in severe COVID-19 without increasing adverse effects. EXPERT OPINION: It seems to me that we have learnt very little from the SIMPLE trial, and this would be predicted from a trial that has no control or placebo group. The results of ACTT1 were reported early after an interim analysis showed that a higher than expected number of recoveries had occurred. There was an indication that remdesivir may be reducing mortality, but this was no statistical significance. The trial is continuing, and the final data are eagerly awaited to determine whether remdesivir is a game-changing remedy or a ripple in the ongoing search for a medicine for the treatment of COVID-19.
  • |Adenosine Monophosphate/administration & dosage/adverse effects/*analogs & derivatives[MESH]
  • |Alanine/administration & dosage/adverse effects/*analogs & derivatives[MESH]
  • |Antiviral Agents/*administration & dosage/adverse effects[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Coronavirus Infections/*drug therapy/mortality/virology[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy/mortality/virology[MESH]
  • |Randomized Controlled Trials as Topic[MESH]
  • |Severity of Illness Index[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box